Publicaciones en colaboración con investigadores/as de Hospital Universitario de Valme (25)

2024

  1. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

    Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618

  2. Feasibility, Safety, and Effects of an Aerobic Training Program with Blood Flow Restriction on Functional Capacity, and Symptomatology in Women with Fibromyalgia: A Pilot Study

    Biomedicines, Vol. 12, Núm. 8

  3. Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 5, pp. 251-256

2023

  1. Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus

    Journal of Infection, Vol. 86, Núm. 1, pp. 41-46

  2. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  3. Hepatic steatosis after switching to integrase inhibitor-based regimens does not parallel short-term weight gain

    AIDS, Vol. 37, Núm. 14, pp. 2259-2262

  4. Poor increase on HAV vaccination coverage among people living with HIV after an immunization-based intervention

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 144-148

  5. Reduced neutralizing antibody response to SARS-CoV-2 vaccine booster dose in people living with HIV with severe immunosuppression

    Journal of medical virology, Vol. 95, Núm. 3, pp. e28602

2022

  1. Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis

    Scientific Reports, Vol. 12, Núm. 1

  2. Incidence of and factors associated with SARS-CoV-2 infection among people living with HIV in Southern Spain after one year of pandemic

    Transboundary and Emerging Diseases, Vol. 69, Núm. 4, pp. e267-e275

  3. Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV

    Clinical Microbiology and Infection

  4. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

  5. Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV

    Clinical Microbiology and Infection, Vol. 28, Núm. 11, pp. 1492-1498

2021

  1. A genome-wide association study on liver stiffness changes during hepatitis c virus infection cure

    Diagnostics, Vol. 11, Núm. 8

  2. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  3. Genomic characterization of host factors related to SARS-CoV-2 infection in people with dementia and control populations: The GR@ACE/DEGESCO study

    Journal of Personalized Medicine, Vol. 11, Núm. 12

  4. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

    eClinicalMedicine, Vol. 40

2020

  1. High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment

    Scientific Reports, Vol. 10, Núm. 1

  2. Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection

    Scientific Reports, Vol. 10, Núm. 1

  3. Toll-Like Receptor 2 Promoter -196 to -174 Deletion Affects CD4 Levels Along Human Immunodeficiency Virus Infection Progression

    The Journal of infectious diseases, Vol. 222, Núm. 12, pp. 2007-2011